---
title: "WIGGANS THOMAS G — Ownership Dossier"
canonical: https://whiteintel.dev/entity/3bc2b895-7e29-5293-84c1-4082f8345510
json: https://whiteintel.dev/api/public/dossier/3bc2b895-7e29-5293-84c1-4082f8345510
identifier: sec:0001208907
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# WIGGANS THOMAS G

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001208907`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/3bc2b895-7e29-5293-84c1-4082f8345510  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/3bc2b895-7e29-5293-84c1-4082f8345510  

## Ownership & control

### Holdings / subsidiaries

- **ONYX PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/7fac90ce-edef-5475-af55-497950d86fee
- **CONNECTIVE THERAPEUTICS INC** (officer) — https://whiteintel.dev/entity/187e2952-1382-5aa0-aacd-6698d0763b28
- **CONNECTIVE THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/187e2952-1382-5aa0-aacd-6698d0763b28
- **TERCICA INC** (director) — https://whiteintel.dev/entity/07ff66af-0694-5431-ab20-decd2513b855
- **Pacira BioSciences, Inc.** (director) — https://whiteintel.dev/entity/7da95720-1de5-53b7-89b1-a3f8c2a07739
- **Jasper Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/446dcbbd-718a-51dd-b3de-5c443a4571da
- **Annexon, Inc.** (director) — https://whiteintel.dev/entity/ea2cc909-5d92-5fdb-931f-208c65007c96
- **CYMABAY THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/806e93a3-924a-5417-98bd-577b36ac2646
- **FS DEVELOPMENT CORP. II** (officer) — https://whiteintel.dev/entity/d3d96da3-e733-5a65-aa9f-e7f0254d7d01
- **FS DEVELOPMENT CORP. II** (director) — https://whiteintel.dev/entity/d3d96da3-e733-5a65-aa9f-e7f0254d7d01
- **FORMA THERAPEUTICS HOLDINGS LLC** (director) — https://whiteintel.dev/entity/acbf6e88-2139-5d18-82cd-7fd49ddaa729
- **DERMIRA, INC.** (director) — https://whiteintel.dev/entity/703e030f-786e-5f44-85db-e876c7bde5a0

…and **6** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **WIGGANS THOMAS G** — https://whiteintel.dev/entity/3bc2b895-7e29-5293-84c1-4082f8345510 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **WIGGANS THOMAS G**. Human view: https://whiteintel.dev/entity/3bc2b895-7e29-5293-84c1-4082f8345510 · Structured JSON: https://whiteintel.dev/api/public/dossier/3bc2b895-7e29-5293-84c1-4082f8345510._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._